Keywords: still, nevirapine, sa, hiv-mothers, well, reinstigation, litigation
Still no nevirapine for SA's HIV-mothers
Article | 15 August 2000
As well as the reinstigation of litigation by the South AfricanPharmaceutical Manufacturers' Association (see facing page), Health Minister Manto Tshabalala-Msimang ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
